ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025

Reuters

06-05

ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025

ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2541073372"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541073372\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2541073372?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541073372","market":"nz","top_or_hot":-1,"title":"ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-05 21:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL88kHrd:1","article_id":"2541073372","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541073372","pubTimestamp":1749128525,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and tim","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","BK4082":"医疗保健设备","LU2008162690.USD":"FIDELITY FUNDS - ASIA PACIFIC OPPORTUNITIES \"A\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","RMD":"瑞思迈","LU2177674079.SGD":"Fidelity Asia Pacific Opportunities A-ACC-SGD (hedged)","BK4504":"桥水持仓"},"translate_title":"ResMed公布了一项研究，将CPAP治疗与睡眠2025心血管急诊减少22%联系起来","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":0.9},"content_text":"ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    \n\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,merge","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}